非典型抗肾小球基底膜疾病
非典型抗肾小球基底膜(抗GBM)病表现为沿GBM的线性IgG沉积但循环抗GBM抗体阴性,病程常较经典抗GBM病更轻、更隐匿,病理表现高度异质。其靶抗原与自身抗体类型可能不同于经典类型,部分病例需高敏感技术或改良检测方可发现抗体,相当比例病例经广泛评估仍无可识别抗体。本文综述了非典型抗GBM病的最新文献。
要点
- 非典型抗GBM病特征为沿GBM线性IgG沉积而循环抗GBM抗体阴性。
- 与经典抗GBM病相比,非典型病例病程常更轻、更隐匿,病理表现更异质。
- 如可行,应尝试用改良检测和高敏感技术广泛评估非典型自身抗体。
核心结论
- 非典型抗GBM病与经典抗GBM病在靶抗原和自身抗体类型上可能不同,病理表现高度异质,部分病例经广泛评估仍无可识别抗体。
研究设计与样本
- 本文为综述,汇总非典型抗GBM病的最新文献。
主要发现
- 非典型抗GBM病沿GBM呈线性IgG沉积,但循环IgG抗GBM抗体阴性。
- 与经典抗GBM病相比,非典型病例在某些情况下病程更轻、更隐匿。
- 经典抗GBM病病理统一表现为弥漫性新月体性和坏死性肾小球肾炎,而非典型抗GBM病病理表现更为异质。
- 部分患者具有与Goodpasture抗原相同的抗原,仅通过高敏感技术(生物传感器分析)检出。
- 部分非典型抗GBM病病例的自身抗体为不同亚类限制如IgG4,或呈单克隆性质。
关键数值与推荐
- 部分病例通过改良检测可检出针对Goodpasture抗原以外抗原/表位结构的抗体。
- IgA和IgM介导的抗GBM病患者循环抗体阴性,因常规检测不检出这些类别的抗体。
- 相当比例的非典型抗GBM病病例经广泛评估仍无可识别抗体。
临床怎么用
- 如可行,应尝试使用改良检测和高敏感技术对非典型自身抗体进行广泛评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atypical anti-glomerular basement membrane (anti-GBM) disease is characterized by linear immunoglobulin G (IgG) deposition along the GBM without circulating IgG anti-GBM antibodies. Compared to classic anti-GBM disease, atypical anti-GBM disease tends to be milder with a more indolent course in certain cases. Moreover, pathologic disease pattern is much more heterogenous in atypical anti-GBM disease than in the classic type, which is uniformly characterized by diffuse crescentic and necrotizing glomerulonephritis. Although there is no single well-established target antigen in atypical anti-GBM disease, the target antigen (within the GBM) and the autoantibody type are hypothesized to be different from the classic type. Some patients have the same antigen as the Goodpasture antigen that are detected only by a highly sensitive technique (biosensor analysis). Some cases of atypical anti-GBM disease have autoantibodies of a different subclass restriction like IgG4, or of monoclonal nature. Antibodies targeting antigen/epitope structure other than the Goodpasture antigen can be detected using modified assays in some cases. Patients with IgA- and IgM-mediated anti-GBM disease are known to have negative circulating antibodies because conventional assays do not detect these classes of antibodies. A significant proportion of cases with atypical anti-GBM disease do not have any identifiable antibodies despite extensive evaluation. Nevertheless, extensive evaluation of atypical autoantibodies using modified assays and sensitive techniques should be attempted, if feasible. This review summarizes the recent literature on atypical anti-GBM disease.
引用
- Bharati J, Yang Y, Sharma P, et al. Atypical Anti-Glomerular Basement Membrane Disease. Kidney Int Rep. 2023. PMID: 37284681. doi:10.1016/j.ekir.2023.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。